Table 3. Univariate and multivariate analysis of factors affecting disease progression in 154 patients with endometrial endometrioid carcinoma.
Metastasis | Univariate P-value | Multivariate P-value | |||
---|---|---|---|---|---|
Histological grade | |||||
G1 | 8/96 | (8.3%) | |||
G2 | 11/36 | (30.6%) | <0.01 | ||
G3 | 10/22 | (45.5%) | <0.01 | 0.025 | |
(G1vs.G2+G3) | |||||
Myometrial invasion | |||||
<1/2 | 9/105 | (8.6%) | |||
≥1/2 | 20/49 | (40.8%) | <0.01 | 0.088 | |
LVSI | |||||
Negative | 6/81 | (7.4%) | |||
Positive | 23/73 | (31.5%) | <0.01 | 0.55 | |
p53 | |||||
Negative | 7/102 | (6.9%) | |||
Stained | 22/52 | (42.3%) | <0.01 | 0.014 | |
ERβ | |||||
Low | 0/86 | (0%) | |||
High | 29/68 | (42.6%) | <0.01 | <0.01 |
LVSI, lymph-vascular space invasion.